These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 19427492)

  • 1. The renin angiotensin aldosterone system in hypertension: roles of insulin resistance and oxidative stress.
    Manrique C; Lastra G; Gardner M; Sowers JR
    Med Clin North Am; 2009 May; 93(3):569-82. PubMed ID: 19427492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obesity and insulin resistance in resistant hypertension: implications for the kidney.
    Rao A; Pandya V; Whaley-Connell A
    Adv Chronic Kidney Dis; 2015 May; 22(3):211-7. PubMed ID: 25908470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [RAAS and insulin resistance].
    Motoshima H; Araki E
    Nihon Rinsho; 2012 Sep; 70(9):1542-9. PubMed ID: 23012801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methods in the evaluation of cardiovascular renin angiotensin aldosterone activation and oxidative stress.
    Manrique C; Lastra G; Habibi J; Wei Y; Morris EM; Stump CS; Sowers JR
    Methods Mol Med; 2007; 139():163-79. PubMed ID: 18287671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salt, aldosterone, and insulin resistance: impact on the cardiovascular system.
    Lastra G; Dhuper S; Johnson MS; Sowers JR
    Nat Rev Cardiol; 2010 Oct; 7(10):577-84. PubMed ID: 20697411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of aldosterone and angiotensin II in insulin resistance: an update.
    Lastra-Lastra G; Sowers JR; Restrepo-Erazo K; Manrique-Acevedo C; Lastra-González G
    Clin Endocrinol (Oxf); 2009 Jul; 71(1):1-6. PubMed ID: 19138313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renin-angiotensin-aldosterone system intervention in the cardiometabolic syndrome and cardio-renal protection.
    Whaley-Connell A; Pavey BS; Chaudhary K; Saab G; Sowers JR
    Ther Adv Cardiovasc Dis; 2007 Oct; 1(1):27-35. PubMed ID: 19124393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of the renin angiotensin aldosterone system: focus on aliskiren.
    Rao MS
    J Assoc Physicians India; 2010 Feb; 58():102-8. PubMed ID: 20653151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The renin angiotensin aldosterone system and insulin resistance in humans.
    Underwood PC; Adler GK
    Curr Hypertens Rep; 2013 Feb; 15(1):59-70. PubMed ID: 23242734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin II reactivation and aldosterone escape phenomena in renin-angiotensin-aldosterone system blockade: is oral renin inhibition the solution?
    Athyros VG; Mikhailidis DP; Kakafika AI; Tziomalos K; Karagiannis A
    Expert Opin Pharmacother; 2007 Apr; 8(5):529-35. PubMed ID: 17376010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renin Angiotensin Aldosterone System Inhibitors in Hypertension: Is There Evidence for Benefit Independent of Blood Pressure Reduction?
    Bavishi C; Bangalore S; Messerli FH
    Prog Cardiovasc Dis; 2016; 59(3):253-261. PubMed ID: 27777044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The renin-angiotensin-aldosterone system: a specific target for hypertension management.
    Weir MR; Dzau VJ
    Am J Hypertens; 1999 Dec; 12(12 Pt 3):205S-213S. PubMed ID: 10619573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Renin-Angiotensin-Aldosterone System in Metabolic Syndrome and Obesity-related Hypertension.
    Kamide K
    Curr Hypertens Rev; 2014 Aug; ():. PubMed ID: 25115697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypertension: renin-angiotensin-aldosterone system alterations.
    Te Riet L; van Esch JH; Roks AJ; van den Meiracker AH; Danser AH
    Circ Res; 2015 Mar; 116(6):960-75. PubMed ID: 25767283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal antagonism of the Renin-Angiotensin-aldosterone system: do we need dual or triple therapy?
    Werner C; Pöss J; Böhm M
    Drugs; 2010 Jul; 70(10):1215-30. PubMed ID: 20568830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maladaptive immune and inflammatory pathways lead to cardiovascular insulin resistance.
    Aroor AR; McKarns S; Demarco VG; Jia G; Sowers JR
    Metabolism; 2013 Nov; 62(11):1543-52. PubMed ID: 23932846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypertension in obesity.
    Kurukulasuriya LR; Stas S; Lastra G; Manrique C; Sowers JR
    Med Clin North Am; 2011 Sep; 95(5):903-17. PubMed ID: 21855699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of glucose metabolism by the renin-angiotensin-aldosterone system.
    Favre GA; Esnault VL; Van Obberghen E
    Am J Physiol Endocrinol Metab; 2015 Mar; 308(6):E435-49. PubMed ID: 25564475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Angiotensin II type 1 receptor on renal NAD(P)H oxidase, oxidative stress and inflammation in nitric oxide inhibition induced-hypertension.
    Rincón J; Correia D; Arcaya JL; Finol E; Fernández A; Pérez M; Yaguas K; Talavera E; Chávez M; Summer R; Romero F
    Life Sci; 2015 Mar; 124():81-90. PubMed ID: 25623850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renin-angiotensin-aldosterone system and oxidative stress in cardiovascular insulin resistance.
    Cooper SA; Whaley-Connell A; Habibi J; Wei Y; Lastra G; Manrique C; Stas S; Sowers JR
    Am J Physiol Heart Circ Physiol; 2007 Oct; 293(4):H2009-23. PubMed ID: 17586614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.